Evidence map›Paper›PMID 22731672›Full record

ArticleThe New England journal of medicine2012

Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.

Erik K Alexander, Giulia C Kennedy, Zubair W Baloch, Edmund S Cibas, Darya Chudova, James Diggans, Lyssa Friedman, Richard T Kloos, Virginia A LiVolsi, Susan J Mandel and 8 more

2 registry-linked trialsAbstract readMulticenter StudyValidation Study
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 369 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
369citing papers in PubMed, 8 pooled it
68.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02681328 active not recruitingnot on this mapstarted 2016, after this paper: background citation

Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules

TypeobservationalSponsorJonsson Comprehensive Cancer CenterRan2016 to 2027Enrolled328ConditionsThyroidArmsAfirma GEC, ThyroSeq v.2, Afirma GSC, ThyroSeq v.3
NCT03061318 completednot on this mapstarted 2015, after this paper: background citation

Validation of a Multi-Genetic Test for the Diagnosis of Indeterminate Thyroid Nodules

TypeobservationalSponsorHernán GonzálezRan2015 to 2017Enrolled3,100ConditionsIndeterminate Thyroid Cytology
3 · Its place in the literature

Who cites it

369 citing papers in PubMed, 8 syntheses or guidelines pooled it, 1,154 citations in OpenAlex.

  1. Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysis.The Journal of clinical endocrinology and metabolism · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. The Diagnostic Performance of Afirma Genomic Sequencing Classifier in Black and Hispanic Patients With Indeterminate Thyroid Nodules.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

309 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 2 countries.

Erik K AlexanderDepartment of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. ekalexander@partners.org
Giulia C Kennedy
Zubair W Baloch
Edmund S Cibas
Darya Chudova
James Diggans
Lyssa Friedman
Richard T Kloos
Virginia A LiVolsi
Susan J Mandel
Stephen S Raab
Juan Rosai
David L Steward
P Sean Walsh
Jonathan I Wilde
Martha A Zeiger
Richard B Lanman
Bryan R Haugen
University of Pennsylvania · USVeracyte (United States) · USHarvard University · USCentro Diagnostico Italiano · ITJohns Hopkins University · USThe Ohio State University · USUniversity of Cincinnati Medical Center · USUniversity of Colorado Denver · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApproximately 15 to 30% of thyroid nodules evaluated by means of fine-needle aspiration are not clearly benign or malignant. Patients with cytologically indeterminate nodules are often referred for diagnostic surgery, though most of these nodules prove to be benign. A novel diagnostic test that measures the expression of 167 genes has shown promise in improving preoperative risk assessment.

methodsWe performed a 19-month, prospective, multicenter validation study involving 49 clinical sites, 3789 patients, and 4812 fine-needle aspirates from thyroid nodules 1 cm or larger that required evaluation. We obtained 577 cytologically indeterminate aspirates, 413 of which had corresponding histopathological specimens from excised lesions. Results of a central, blinded histopathological review served as the reference standard. After inclusion criteria were met, a gene-expression classifier was used to test 265 indeterminate nodules in this analysis, and its performance was assessed.

resultsOf the 265 indeterminate nodules, 85 were malignant. The gene-expression classifier correctly identified 78 of the 85 nodules as suspicious (92% sensitivity; 95% confidence interval [CI], 84 to 97), with a specificity of 52% (95% CI, 44 to 59). The negative predictive values for "atypia (or follicular lesion) of undetermined clinical significance," "follicular neoplasm or lesion suspicious for follicular neoplasm," or "suspicious cytologic findings" were 95%, 94%, and 85%, respectively. Analysis of 7 aspirates with false negative results revealed that 6 had a paucity of thyroid follicular cells, suggesting insufficient sampling of the nodule.

conclusionsThese data suggest consideration of a more conservative approach for most patients with thyroid nodules that are cytologically indeterminate on fine-needle aspiration and benign according to gene-expression classifier results. (Funded by Veracyte.).

Indexed as

Gene ExpressionAdolescentAdultAgedAged, 80 and overAlgorithmsBiomarkers, TumorBiopsy, Fine-NeedleDiagnosis, DifferentialDouble-Blind MethodFemaleGene Expression ProfilingHumansMaleMiddle AgedOligonucleotide Array Sequence AnalysisBiomarkers, TumorRNA, Messenger

Identifiers

PMID22731672
OpenAlexW2152446218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.